ONCOLOGY Vol 26 No 5 | Oncology

Proton Radiotherapy: The Good, the Bad, and the Uncertain

May 15, 2012

Proton radiotherapy is here to stay. Despite the high initial cost, the number of proton therapy machines in the United States and elsewhere is increasing rapidly.[1] The major questions now relate to defining and optimizing their appropriate use.

Identifying Appropriate Patient Groups and Drug Targets in DLBCL

May 15, 2012

In their article in this issue of ONCOLOGY, Nastoupil, Rose, and Flowers give a very careful assessment of the options for treating diffuse large B-cell lymphoma (DLBCL), with a focus on the importance of dose density in improving outcomes in this disease.

Genetic Testing in Cancer: Ethical Issues

May 15, 2012

In 2002, the American Society of Clinical Oncology (ASCO) established the Cancer Prevention Committee (CAPC), which was formed in the hope of ensuring the integration of cancer prevention into oncology practice and research.[1]

Diffuse Large B-Cell Lymphoma: Current Treatment Approaches

May 15, 2012

This article examines clinical and biological features of DLBCL patients with poor outcomes, and reviews recent studies addressing alternatives to standard front-line management strategies together with unresolved questions.

Breast Cancer Screening: The Evolving Evidence

May 15, 2012

In this paper, the historic and recent evidence supporting the value of breast cancer screening will be described, along with the underpinnings of the current debate over the relative and absolute benefit of regular mammography screening.